Stock Analysts

Pharma Stock Roundup: AZN’s Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm

Key announcements this week included the FDA approval for a second indication of AstraZeneca’s AZN Imfinzi and an acquisition offer by Merck MRK . AbbVie ABBV presented new data on two pipeline candidates and announced an Alzheimer’s deal with a small biotech. Recap of the Week’s Most Important Stories AstraZeneca’s Imfinzi Gains FDA Nod in Second Indication : AstraZeneca’s PD-L1 inhibitor, Imfinzi gained FDA approval for an early-stage lung cancer indication, making it the drug’s second FDA approval […]

Stock Analysts

Amdocs Closes Vubiquity Buyout, Expands Media Footprint

In a bid to expand the media and entertainment business further, Amdocs Limited DOX recently completed the acquisition of a leading provider of digital content services and technology solutions — Vubiquity, Inc. The latest move will benefit Amdocs’ customers and end users globally by adding premium content capabilities such as licensing, processing and delivery to the company’s portfolio. Rationale Behind the Acquisition The move positions Amdocs at the center of growing convergence across the content community and video distributors globally […]